GlowDNA

Active DNA Repair + Regeneration Platform

The Next Era of Skincare

Seed Round: $1.5M

A Fundamental Shift is Happening

Skincare is moving from protection → Active cellular DNA repair
Consumers demand clinically-proven, biophysics-backed active solutions
Clinical dermatology and luxury consumer skincare are completely merging

Pigmentation is DNA Damage

UV radiation creates damaging DNA lesions in epidermal cells
This triggers the cellular p53 defense pathway
Resulting in hyperpigmentation, melasma, and PIH

UV DNA Damage Mapping

Current Solutions Are Broken

Sunscreens

Prevention Only

Fails to repair pre-existing UV lesions or reverse photo-damage.

Hydroquinone

Toxic Profiles

Highly toxic and banned in major regions; unsafe for long-term therapy.

Lasers

High Relapse

Extremely expensive, painful, with frequent hyperpigmentation rebound.

DNA Repair is a Global Category

Active Photolyase is already widely endorsed and used in clinical dermatology
Dermatological products are prescribed globally to reverse photo-damage
This is expanding into a massive, premium consumer skincare segment ($1B+ TAM)

Regenerative Skincare is Exploding

PDRN (Polynucleotide) is used in over 5,000+ top aesthetics clinics globally
Massive consumer adoption across premier K-beauty and luxury global markets
The fastest-growing ingredient class in high-performance dermatology today

The Competitive Gap

DNA Repair

Mainly preventive sunscreen additives

+

Regeneration

Mainly clinical injections & micro-needling

No integrated, daily consumer topical system exists.

LumiDNA™ — Integrated Biology

Photolyase Enzymes → Active, light-driven DNA lesion excision
Marine PDRN → Accelerated cellular tissue regeneration
Liposomal Nanospheres → Deep dermal cellular delivery system

LumiDNA™ Liposomal Delivery

Mechanism of Action

01 UV radiation causes structural DNA lesions (CPDs) inside epidermal nuclei.

02 Active Photolyase captures light energy to bind and actively restore lesions.

03 PDRN provides nucleotide precursors, accelerating full tissue healing and structure.

04 The p53 damage response terminates, effectively preventing melanogenesis and spots.

Clinical 4-Step System

A clinical regimen designed to actively repair, regenerate, shield, and protect dermal cells from environmental stressors.

✦ Step 1 (Correct): LumiDNA Eyes & Face Serum

✦ Step 2 (Shield): LumiDNA Protective Sunscreen

✦ Step 3 (Recover): LumiDNA Restorative Cream

Correct

Eye Serum

Actives: Liposomal Photolyase, Marine PDRN, Tranexamic Acid & Niacinamide

Shield

Sunscreen

Actives: 2.0% Photolysomes®, 2.0% Iron Oxides (HEVL Filter) & 15.0% Zinc Oxide

Recover

Restorative

Actives: Active Photolyase + Marine PDRN, Ceramides NP/AP/EOP & Squalane

Why Now

The absolute boom in clinical skincare is completely reshaping consumer habits.
Hyper-informed consumers actively seek next-generation biological ingredients.
Dermatologist advocacy and professional influencer channels dominate cosmetic search.

Market Opportunity

$1.8B

Total Addressable Market

Global clinical and aesthetic skincare category

$300M

Serviceable Addressable Market

Premium DNA repair and regenerative topicals

$30M

Early Target

Initial launch across tier-1 clinical networks

Go-To-Market Strategy

Clinics & Dermatologists 50%

Premium Luxury Retail 30%

Direct-to-Consumer 20%

Business Model

Premium Direct-to-Consumer

Clinical Aesthetic Networks

Premium Wellness Retailers

Continuous Subscriptions

Advanced IP & Ingredient Licensing

Financials

High product gross margins of ~75%
Operational break-even projected at Month 22
Extremely scalable capital layout and positive working capital

Our Competitive Moat

Pioneering Science

First proprietary delivery model uniting high-activity light-driven Photolyase and regenerative marine Polynucleotides.

Advanced Delivery

Proprietary multi-lamellar liposomes engineered specifically to deeply transport enzymes through the epidermal layer.

Clinical Lock-In

Strategic, exclusive contracts and formulations built hand-in-hand with leading international dermatology circles.

The Founders & Team

Biophysics Specialists: Deep structural research on active photolyases and repair pathways.
Dermatology Experts: World-renowned clinical leaders in hyperpigmentation treatment.
Commercial Scaling: Veteran executives who scaled premier consumer skincare brands.

DK

Dr. Goutham Kodali

Co-Founder & Chief Scientist

PK

Pratyoosha Kodali

Chief Operating Officer (COO)

Raising $1.5M Seed

Securing leadership in the premium DNA skincare category:

Clinical Validation & Trials 40%

Supply Chain & Formulations 30%

Global Go-To-Market Launch 30%

Why GlowDNA Wins

Active Photolyase DNA Repair CLINICALLY PROVEN

Tissue-Regenerating Marine PDRN CLINICALLY PROVEN

GlowDNA Integrated System The First Topical Platform

Defining the Active DNA Repair Skincare Category

Thank You